SCHEDULE: Patrick J. Crutcher Reduces Stake in IBIO, Inc. Below 5% Threshold

Patrick J. Crutcher has filed an Amendment to Schedule 13G, indicating a reduction in beneficial ownership of IBIO, Inc. common stock to 3.1%, triggering an exit filing.

Summary

• Patrick J. Crutcher, the Reporting Person, has filed an Amendment No. 2 to Schedule 13G regarding his beneficial ownership in IBIO, INC.
• As of June 30, 2025, the Reporting Person beneficially owns 847,044 shares of IBIO, INC. Common Stock.
• This ownership represents 3.1% of the outstanding shares of Common Stock, based on 27,472,651 shares outstanding as disclosed in the Issuer's final prospectus filed on June 24, 2025.
• The 847,044 shares consist of 546,606 shares of Common Stock and warrants to purchase up to 300,438 shares of Common Stock.
• This filing is an 'exit filing' for the Reporting Person, meaning their beneficial ownership has fallen below the 5% threshold requiring Schedule 13G reporting.

Sentiment

Score: 4

Explanation: The sentiment is slightly negative due to a significant beneficial owner reducing their stake below the reporting threshold, which can be interpreted as a lack of confidence or a strategic divestment.

Negatives

• A significant beneficial owner, Patrick J. Crutcher, has reduced their stake in IBIO, INC. to below the 5% reporting threshold, indicating a divestment of a portion of their holdings.

Industry Context

This filing is a routine compliance disclosure by an individual investor and does not provide specific insights into broader industry trends or competitive dynamics within the biotechnology sector.

Stakeholder Impact

• Shareholders may view the reduction in a significant investor's stake as a negative signal, potentially impacting investor confidence and share price.

Key Dates

Keywords

IBIO, Patrick J. Crutcher, Schedule 13G, Beneficial Ownership, Common Stock, SEC Filing, Shareholder, Investment, Biotechnology